Amylase-producing lung adenocarcinoma with an anaplastic lymphoma kinase fusion mutation: a case report
We suggest that serum amylase may be a tumor marker that may lead to a more effective approach to the diagnosis and treatment of related diseases.
Authors
- Mengru Jian
- Chenshi Lin (ORCID: https://orcid.org/0000-0001-9412-8934)
- Zhiqiang Cai (ORCID: https://orcid.org/0000-0002-7380-8110)
- Shuiqing Yang (ORCID: https://orcid.org/0000-0003-1864-814X)
- Yan Li (ORCID: https://orcid.org/0000-0001-6155-0389)
- Wenbin Li (ORCID: https://orcid.org/0000-0003-3096-4831)
- Meiqi Wang (ORCID: https://orcid.org/0000-0003-2417-1480)
- Jun Xu
- Difeng Guo
Institutions
- Yangtze University (CN)
- Qianjiang Central Hospital (CN)
Publication Details
- Journal
- Laboratory Medicine
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1093/labmed/lmaf017
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05